Download or read book The Social Management of Biotechnology written by René von Schomberg and published by . This book was released on 1996 with total page 196 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Biotechnology for Sustainability and Social Well Being written by Pau Loke Show and published by MDPI. This book was released on 2021-09-01 with total page 250 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book covers the latest development of bioprocess technology including theoretical, numerical, and experimental approaches in biotechnology as well as green technology that bridge conventional practices and Industry 4.0. Bioprocessing is one of the key factors in several emerging industries of biofuels, used in the production of biogas, bioethanol, and biodiesel; industrial enzymes; waste management through biotechnology; new vaccines; and many more. It is hoped that the novel bioprocess and green biotechnologies presented in this book are useful in assisting the global community in working towards fulfilling the Sustainable Development Goals (SDG) of the United Nations.
Download or read book The Social Management of Genetic Engineering written by Peter Wheale and published by Routledge. This book was released on 2019-05-23 with total page 342 pages. Available in PDF, EPUB and Kindle. Book excerpt: First published in 1998, this volume why and how genetic engineering has emerged as the technology most likely to change our lives, for better or worse, in the opening century of the third millennium. Over twenty international experts, including moral philosophers and social scientists, describe the issues and controversies surrounding modern biotechnology and genetic engineering. They explore ways in which lay individuals and groups can join in an effective and constructive dialogue with scientists and industrialists over the assessment, exploitation and safe management of these new and important technologies. Topics covered include a discussion of the issues surrounding ‘Dolly’, the cloned sheep, the politics and ethics of the international research programme to sequence the entire human genome, the ethical questions raised by the creation of transgenic farm animals, the morality of genetic experimentation on animals, the controversy surrounding the patenting of genetic material and of the transgenic animals themselves, the ethical implications of engineering animals for transplanting their organs into humans, and the environmental hazards of releasing genetically engineered organisms.
Download or read book The Economic and Social Dynamics of Biotechnology written by John de la Mothe and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 282 pages. Available in PDF, EPUB and Kindle. Book excerpt: `Biotechnology' - the integrated use of biochemistry, microbiology, and chemical engineering for the technological application of the capabilities of microbes and cultured tissue cells - is quickly becoming pervasive and challenging, rapidly developing both new techniques and industries. The Economic and Social Dynamics of Biotechnology - a joint project between Statistics Canada, the Program of Research on Innovation, Management and Economy (PRIME) at the University of Ottawa, and CIRANO at the University of Quebec in Montreal - brings together economic, social, and statistical views on the dynamics of this set of emerging technologies. It examines the costs as well as the benefits - the challenges as well as the choices - of the rapidly expanding science-based world of biodiversity, biopharmaceuticals, and bioinformatics, and it provides suggestions for future work and research. This project fits into an ongoing research program at Statistics Canada to develop meaningful indicators for science, technology, and innovation in a technology-intensive economy. This book tells the story of the inner workings of innovation systems, technological systems, and competence blocs in the production, use, and diffusion of knowledge.
Download or read book Strategic Alliances as Social Facts written by Mark De Rond and published by Cambridge University Press. This book was released on 2003-06-19 with total page 252 pages. Available in PDF, EPUB and Kindle. Book excerpt: How can we explain a proliferation of alliances when the probability of failure is higher than success? And why have we emphasized their order, manageability and predictability whilst acknowledging that they tend to be experienced as messy, politically charged and unpredictable? Mark de Rond, in this provocative book, sets out to address such paradoxes. Based on in-depth case studies of three major biotechnology alliances, he suggests that we need theories to explain idiosyncracy as well as social order. He argues that such theories must allow for social conduct to be active and self-directed but simultaneously inert and constrained, thus permitting voluntarism, determinism, and serendipity alike to explain causation in alliance life. The book offers a highly original combination of insights from social theory and intellectual history with more mainstream strategic management and organizations literature. It is a refreshing and thought-provoking analysis that will appeal to practitioner and academic researcher alike.
Download or read book Preparing for Future Products of Biotechnology written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-07-28 with total page 231 pages. Available in PDF, EPUB and Kindle. Book excerpt: Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
Download or read book Women in Biotechnology written by Francesca Molfino and published by Springer Science & Business Media. This book was released on 2008-08-05 with total page 359 pages. Available in PDF, EPUB and Kindle. Book excerpt: Johannes Klumpers Biotechnologies, such as genetic engineering, cloning and biodiversity, raise many legal and ethical concerns, so it is important that people understand these issues and feel able to express their opinions. This is why the European Commission has been, for a number of years, supporting actions to improve communication among scientists in these diverse areas. The project ‘Women in Biotechnology’ (WONBIT), financed under the 6th Framework programme of the European Commission, is an excellent example of what can be done to target opinion-formers such as scientists, economists and lawyers in bottom-up activities, and to encourage a debate on gender issues triggered by developments in the life sciences. WONBIT gave rise to a successful international conference highlighting the importance of adopting good practices and ethical considerations in parallel with the rapid pace of progress in biotechnology – from a woman’s point of view. In particular, the conference addressed women in decision-making positions in b- technology with specific reference to scientific excellence, social competencies and management qualities as well as issues relating to environment, society and the younger generation. But it did not stop there: a key part of the conference was dedicated to stimulating public debate among non-specialists, which has led to a number of recommen- tions to policy-makers on better communication in biotechnology, on taking better account of the gender aspects of research, and on involving more women in the decision-making process that surrounds developments in biotechnology.
Download or read book Biotechnology and the Future of Society written by The Emirates Center for Strategic Studies and Research and published by Emirates Center for Strategic Studies and Research. This book was released on 2004-10-20 with total page 37 pages. Available in PDF, EPUB and Kindle. Book excerpt: Breakthroughs in biotechnology are redefining the very concept of life, transforming society and presenting unprecedented opportunities and challenges: Will human genome sequencing help to treat genetic diseases and indefinitely prolong life? Will stem cell therapy and tissue engineering allow routine regeneration and replacement of diseased organs? Can new diagnostic tests revolutionize medicine and healthcare? Will genetic engineering allow parents to design perfect babies? Can nature’s workshop inspire superior biomaterials that transform industries? Will genetically modified super crops feed a hungry world? With biotechnology set to be the driving force of the twenty-first century, mastery of the life sciences will be the key to wealth generation and economic ascendancy. Can the Arab World regain its past supremacy in these fields? Can it benefit from the biotech revolution while avoiding its perils? Such implications were debated by experts at the ECSSR Eighth Annual Conference titled Biotechnology and the Future of Society: Challenges and Opportunities, held from January 11-13, 2003 in Abu Dhabi, United Arab Emirates. This volume of conference presentations explores the broad impact of the biotech revolution, highlighting trends in healthcare and molecular medicine, the genetic revolution in agriculture, the future of materials production, new drug discovery technologies and national security issues, including the threat of bio-terrorism. It also examines the complex ethical, legal and social issues raised by the biotech revolution that need to be resolved by governments and decision makers.
Download or read book Science Lessons written by Gordon M. Binder and published by Harvard Business Review Press. This book was released on 2008 with total page 326 pages. Available in PDF, EPUB and Kindle. Book excerpt: Under Gordon Binder's leadership, Amgen became the world's largest and most successful biotech company in the world. This text describes what it really takes to manage risk, financing, creative employees, and intellectual property on the international stage.
Download or read book Managing Biotechnology written by Francoise Simon and published by John Wiley & Sons. This book was released on 2017-09-01 with total page 317 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Download or read book A Biotech Manager s Handbook written by M O'Neill and published by Elsevier. This book was released on 2012-05-02 with total page 414 pages. Available in PDF, EPUB and Kindle. Book excerpt: A biotech manager's handbook lays out - in a simple, straightforward manner - for the manager or would-be entrepreneur the basic principles of running a biotech company. Most managers in biotechnology companies are working in their first company or in their first managerial role. Their expertise and experience in the scientific part of the work can be taken as a given but there is a whole range of other skills to be learned and areas of expertise to come to terms with. Small companies do not have big budgets to hire people or time to become an expert in so many areas. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Succeeding chapters deal with the basics of intellectual property, perspectives from a university technology transfer office and how to raise some initial funding from an investor and entrepreneur. No other 'how to' manual exists for this sector Written by a range of expert professionals in each area, all in one book Is the only 'bench to bedside' book covering the whole spectrum of development
Download or read book Biotechnology Entrepreneurship written by Craig Shimasaki and published by Academic Press. This book was released on 2014-04-08 with total page 489 pages. Available in PDF, EPUB and Kindle. Book excerpt: As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts
Download or read book Building Biotechnology written by Yali Friedman and published by Thinkbiotech. This book was released on 2006 with total page 306 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Download or read book Reconstructing biotechnologies written by Guido Ruivenkamp and published by BRILL. This book was released on 2023-08-28 with total page 367 pages. Available in PDF, EPUB and Kindle. Book excerpt: The main subject of this publication is the co-creation of society and biotechnology. The authors do not treat society and biotechnology as separate domains, instead they consider technologies as socially constructed. The main focus of this publication is on agro-biotechnologies and the contributors present perspectives for reconstruction both from and in 'the North' and 'the South'. Reconstructing biotechnologies offers a range of critical social analyses confronting the actuality of biotechnology with the potentialities of its social reconstruction. In doing that, the book develops and merges literature from four different disciplines, namely (i) critical theory and its analyses of technology and power, (ii) political economy, critically assessing the interrelationship between economy, politics and technology, (iii) social constructivism, which holds that technology is the product of agency and knowledge systems, and (iv) the analysis of rural society and agrarian technologies in rural sociology. Reconstructing biotechnologies introduces exciting approaches and examples into the social reshaping of biotechnologies. It brings together critical examinations of contemporary biotechnology development and puts forward possible alternatives written by critical scholars. The contributions in this publication are for students and scholars in a wide range of disciplines such as social and political sciences, science and technology studies, and development studies. The editors of the book are associated with the Social Sciences Department of Wageningen University in the Netherlands and the Graduate School of Economics of Kyoto University in Japan. They have published extensively on social and political theory and biotechnology.
Download or read book The Capacity to Innovate written by Sarah Giest and published by University of Toronto Press. This book was released on 2021 with total page 200 pages. Available in PDF, EPUB and Kindle. Book excerpt: "In The Capacity to Innovate, Sarah Giest provides insight into the collaborative and absorptive capacities needed to provide public support to local innovation through cluster organizations. The book offers a detailed view of the vertical, multi-level, and horizontal dynamics in clusters and cluster policy and addresses how they are managed and supported. Using the biotechnology field as an example, Giest highlights challenges in the collaborative efforts of public bodies, private companies, and research institutes to establish a successful eco-system of innovation in this sector. The book argues that cluster policy in collaboration with cluster organizations should focus on absorptive and collaborative capacity elements missing in the cluster context in order to improve performance. Currently, governments operate at different levels--local to supranational--in order to support clusters, and cluster policies are often pursued in parallel to other programs. As the book shows, this can lead to uncoordinated efforts and ineffective cluster strategies. Relational dynamics are often overlooked when working backwards from performance indicators, since their effects are largely indirect but Giest demonstrates that both the cluster organization and the cluster eco-system play a role. The Capacity to Innovate advocates for a coordinated effort by government and cluster organizations to support capacity elements lacking within the specific cluster context."--
Download or read book Sustainability and Life Cycle Assessment in Industrial Biotechnology written by Magnus Fröhling and published by Springer Nature. This book was released on 2020-06-16 with total page 363 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book reviews the assessment of industrial biotechnology products and processes from a sustainable perspective. Industrial Biotechnology is a comparably young field which comes along with high expectations with regard to sustainability issues. These stem from the promise of reducing greenhouse gas emissions and replacing fossil resources in the near or later future and using green technology, i.e. more environmentally friendly technologies. The intended economic, ecological and social benefits, however, need to be proven, resulting in a variety of challenges, both from a methodological and application point of view. In this book, specific assessment and application topics of industrial biotechnology are addressed, highlighting challenges and solutions for both developers and users of assessment methods. In twelve chapters, experts in their particular fields define the scope, characterize industrial biotechnology and show in their contributions the state of the art, challenges and prospects of assessing industrial biotechnology products and processes. The chapter 'Societal and Ethical Aspects of Industrial Biotechnology' of this book is available open access under a CC BY 4.0 license at link.springer.com
Download or read book The Global Genome written by Eugene Thacker and published by MIT Press. This book was released on 2006-09-08 with total page 450 pages. Available in PDF, EPUB and Kindle. Book excerpt: How global biotechnology is redefining "life itself." In the age of global biotechnology, DNA can exist as biological material in a test tube, as a sequence in a computer database, and as economically valuable information in a patent. In The Global Genome, Eugene Thacker asks us to consider the relationship of these three entities and argues that—by their existence and their interrelationships—they are fundamentally redefining the notion of biological life itself. Biological science and the biotech industry are increasingly organized at a global level, in large part because of the use of the Internet in exchanging biological data. International genome sequencing efforts, genomic databases, the development of World Intellectual Property policies, and the "borderless" business of biotech are all evidence of the global intersections of biology and informatics—of genetic codes and computer codes. Thacker points out the internal tension in the very concept of biotechnology: the products are more "tech" than "bio," but the technology itself is fully biological, composed of the biomaterial labor of genes, proteins, cells, and tissues. Is biotechnology a technology at all, he asks, or is it a notion of "life itself" that is inseparable from its use in the biotech industry? The three sections of the book cover the three primary activities of biotechnology today: the encoding of biological materials into digital form—as in bioinformatics and genomics; its recoding in various ways—including the "biocolonialism" of mapping genetically isolated ethnic populations and the newly pervasive concern over "biological security"; and its decoding back into biological materiality—as in tissue engineering and regenerative medicine. Thacker moves easily from science to philosophy to political economics, enlivening his account with ideas from such thinkers as Georges Bataille, Georges Canguilhem, Michel Foucault, Antonio Negri, and Paul Virilio. The "global genome," says Thacker, makes it impossible to consider biotechnology without the context of globalism.
